Rob Abenante, president and CEO of Abattis, indicated that South Korea imported about “20 to 30 tons” of hemp seed weekly from Canada last year.

“With GD Pharma’s established distribution channels in the region, we believe the potential for our products in South Korea is very bright,” he said in a press release. “… We see major potential with this market.”

The companies plan to develop new formulations with a focus on CBD-infused products. The products will be developed through Abattis subsidiary Northern Vine Canada Inc., and will be sold in Europe and South Korea by GD Pharma and throughout North America by Vergence Naturals Ltd, another Abattis subsidiary.

Don Ki Kim, GD Pharma CEO, explained the firm will “source the marketing, sales, and distribution channels” that will be beneficial for both firms.

“We are excited to demonstrate our expertise in sales and marketing, as well as timely and compliant delivery of revenues overseas to our partners,” Kim said in a statement. “We are currently searching for the most suitable partner in the pharmaceutical sector in order to seek more medical benefits from CBD, so that we can work with Abattis in their lab to formulate products together.”

TG Branfalt

TG is a journalist by trade and has been covering cannabis industry news for Ganjapreneur.com since 2014. He is also the host of the Ganjapreneur.com Podcast and currently lives in Burlington, Vermont.

DISCLAIMER: Ganjapreneur.com is intended as an educational resource for law-abiding professionals and those who are curious about entrepreneurial and/or investment opportunities in emerging markets. We do not offer investment advice, and we encourage all visitors and readers to do their own due dilligence before investing in any of the companies or markets that we write about. Be advised that possessing, using, distributing and selling cannabis are all federal crimes in the United States of America and the articles, pages, links, and other types of information on this site are not intended to assist you in violating federal law. Ganjapreneur.com and all associated entities and individuals are not responsible for third party content and/or links published on this website.